Increase in the deposition of aggregated protein in the glomeruli of spontaneously diabetic mice

Journal of Pharmacological Sciences

Volumn 99, Issue 3, 2005, Pages 287-293

  Nagamatsu, Tadashi ^a   Hirasawa, Yasushi ^a,b   Matsui, Yukari ^b   Ohtsu, Shoko ^b   Yamane, Kazusuke ^b   Toyoshi, Tohru ^b   Kyuki, Kohei ^b   Suzuki, Yoshio ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Nihon Bioresearch Inc   (Japan)

Author keywords

Aggregated protein; Diabetic mice; Diabetic nephropathy; Glomeruli; Hyperglycemia

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION;

EID: 28044438696     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ04052X     Document Type: Article

References (32)

1. y mice. Life Sci. 2004;75:869-880.
2. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol. 2003;284:1138-1144.
3. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes. 2003;52:2570-2577.
4. Kennedy L, Mehl TD, Riley WJ, Merimee TJ. Non-enzymatically glycosylated serum protein in diabetes mellitus: an index of short-term glycaemia. Diabetologia. 1981;21:94-98.
5. Danze PM, Tarjoman A, Rousseaux J, Fossati P, Dautrevaux M. Evidence for an increased glycation of IgG in diabetic patients. Clin Chim Acta. 1987;166:143-153.
6. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Atsumi T, et al. Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes. 1993;42:826-832.
7. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet. 1994;343:1519-1522.
8. Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, et al. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia. 2003;46:1140-1152.
9. Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, et al. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes. 1997;46:895-899.
10. Axe SR, Katz SM, Lavine R. Immunoglobulin deposition in the microvasculature of the streptozotocin-induced diabetic rat. Lab Invest. 1981;45:229-233.
11. Ishizaki M, Masuda Y, Fukuda Y, Yamanaka N, Masugi Y, Shichinohe K, et al. Renal lesions in a strain of spontaneously diabetic WBN/Kob rats. Acta Diabetol Lat. 1987;24:27-35.
12. Nagamatsu T, Suzuki Y. Antinephritic effect of prostaglandin E1 on serum sickness nephritis in rats (5). Effect of PGE1 on disposal of heat-aggregated bovine serum albumin in the glomerulus. Jpn J Pharmacol. 1988;46:397-402.
13. Ford PM. Glomerular localization of aggregated protein in mice; effect of strain difference and relationship to systemic macrophage function. Br J Exp Pathol. 1975;56:307-313.
14. Nagamatsu T, Nagao T, Koseki J, Sugiura M, Nishiyama T, Suzuki Y. Involvement of prostaglandin E2 in clearance of aggregated protein via protein kinase A in glomeruli. Jpn J Pharmacol. 2001;85:139-145.
15. DeFronzo RA, Ferrannini E, Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med. 1983;74:52-81.
16. Iwatsuka H, Shino A. Studies on diabetogenic action of obesity in mice: congenital insulin resistance of KK mice. Endocrinol Jpn. 1970;17:535-540.
17. y mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels. 1987;24:297-303.
18. Nagamatsu T, Nagao T, Nomura Y, Suzuki Y. Thromboxane A2 interferes with a disposal process of aggregated protein in glomeruli. Jpn J Pharmacol. 1997;75:381-390.
19. Nagamtsu T, Ishikami H, Nishiyama T, Suzuki Y. Induction of cyclooxigenase-2 expression in glomeruli by aggregated protein. Jpn J Pharmacol. 2002;89:373-379.
20. Assman KJ, van Son JP, Koene RA. Improved method for the isolation of mouse glomeruli. J Am Soc Nephrol. 1991;2:944-946.
21. Hofmann CA, Edwards CW, Hillman RM, Colca JR. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology. 1992;130:735-740.
22. Bonini JA, Colca JR, Dailey C, White M, Hofmann C. Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes. Am J Physiol. 1995;269:E759-E765.
23. Bhatwadekar AD, Ghole VS. Rapid method for the preparation of an AGE-BSA standard calibrator using thermal glycation. J Clin Lab Anal. 2005;19:11-15.
24. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A. 1990;87:9010-9014.
25. Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes. 2004;53:1831-1840.
26. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest. 2001;108:261-268.
27. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 1988;240:1546-1548.
28. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol. 1999;10:2569-2576.
29. Wei P, Lane PH, Lane JT, Padanilam BJ, Sansom SC. Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes. Diabetologia. 2004;47:1541-1549.
30. Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol. 2000;11:71-79.
31. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 1998;41:1426-1434.
32. Alvestrand A, Bergstrom J. Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome. Lancet. 1984;8370:195-197.